These GBM cells were subject to drug treatment with TMZ, A5 or C1, and the reduction of ABCB1 expression significantly lead to a more potent TMZ but not to A5 or C1 response by U3017MG and U3031MG cells (Fig. 5I and J). The gene discussed is ABCB1; the disease is glioblastoma.